Exact Sciences Corporation (EXAS) Jumps 6.27% on January 14

Equities Staff |

Exact Sciences Corporation (EXAS) was among the biggest gainers on the Russell 2000 for Thursday January 14 as the stock popped 6.27% to $7.12, representing a gain of $0.42 per share. Some 2 million shares traded hands on 12,690 trades, compared with an average daily volume of 3.37 million shares out of a total float of 96.34 million. The stock opened at $6.96 and traded with an intraday range of $7.19 to $6.63.

After today's gains, Exact Sciences Corporation reached a market cap of $685.93 million. Exact Sciences Corporation has had a trading range between $32.85 and $6.65 over the last year, and it had a 50-day SMA of $8.96 and a 200-day SMA of $18.66.

Exact Sciences Corp is a molecular diagnostics company currently focused on the early detection and prevention of colorectal cancer. It has developed a non?invasive, patient friendly screening test called Cologuard(R).

Exact Sciences Corporation is based out of Madison, WI and has some 236 employees. Its CEO is Kevin T. Conroy.

For a complete fundamental analysis analysis of Exact Sciences Corporation, check out Equities.com’s Stock Valuation Analysis report for EXAS. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Taranis Resources Inc.

Taranis Resources Inc is an exploration stage company. The Company along with its subsidiaries is engaged in the acquisition and exploration of mineral properties. Its projects include Thor Property in…

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

Wealthfront

Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…